Exabis Library
Welcome to the e-CCO Library!
P0337: Incidentally Diagnosed Inflammatory Bowel Disease: Prevalence and Long-Term Outcomes
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0338: Early identification of pediatric inflammatory bowel disease based on machine learning with non-invasive data
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P033: Anti-TNF-α therapy normalises aberrant cytokine production and homing profile of circulating dendritic cells in Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P033: Dendritic cells from patients with active IBD imprint pro-inflammatory α4β7+CLA+ T cells with potential for gut and skin homing
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P033: DSS-induced colitis is attenuated in sigma-1 receptor knockout mice
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P033: Periostin regulates ER-stress mediated intestinal subepithelial myofibroblasts function to promote fibrosis in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P033: Single-cell analysis of gut mucosal- and peripheral blood cells in ulcerative colitis patients undergoing vedolizumab treatment
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P033: The assessment of serum cytokines at baseline could predict mucosal healing in patients with Crohn's disease treated with ustekinumab. A prospective study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P033: The efficacy of tonsil-derived mesenchymal stem cells conditioned medium in chronic colitis model
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P034 GB004, a novel gut-targeted prolyl hydroxylase inhibitor, induces HIF-1α target genes and is efficacious in mouse colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0340: Endo-Histo Foundational Fusion Model: A Novel Artificial Intelligence Approach for Predicting Histologic Remission and Early Response to Therapy in a Phase 2 Ulcerative Colitis Clinical Trial
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0341: Variation in healthcare utilisation amongst IBD care centres in Australia and New Zealandx7x7x7 Crohn’s Colitis Care Data Insight’s Program.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0342: Quantitative faecal immunochemical test (qFIT) is comparable to calprotectin as a biomarker of IBD: Prospective longitudinal analysis of disease activity and endoscopic mucosal healing
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0343: Gender Identity and Inflammatory Bowel Disease: The Patient Perspective
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0344: Comparative analysis of a simple POPSIL score with Lémann Index to define the burden of organ damage in Crohn’s disease.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0345: Tailoring Crohn’s disease surveillance in clinical remission: new insights from the Lewis score
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0346: Pouch Fistulas: Experience From a Tertiary Center
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0347: Correlation between histologic disease activity in the distal and proximal colon in Ulcerative Colitis: A flexible sigmoidoscopy is insufficient to assess histology
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0348: Ultrasound enterography with a novel ultrasound contrast agent for Crohn's Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0349: Gasdermin D: A New Inflammatory Biomarker in Assessing Clinical Disease Activity in Crohn’s Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM